Beranda › Kondisi Pasca-COVID (Long COVID) › Ohio › Cincinnati
Uji klinis Kondisi Pasca-COVID (Long COVID) di Cincinnati, OH
4 studi untuk Kondisi Pasca-COVID (Long COVID) mencari peserta di lokasi sekitar Cincinnati (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease
Menerima pesertaFase 3
- Hometown Urgent Care and Research, Cincinnati
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Menerima pesertaFase 3
- University of Cincinnati Medical Center, Cincinnati
- University of Cincinnati College of Medicine (UC Holmes), Cincinnati
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Cincinnati Childrens Hospital Medical Center, Cincinnati
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Menerima pesertaFase 3
- Cincinnati Children's Hospital Medical Center, Cincinnati
Uji klinis Kondisi Pasca-COVID (Long COVID) di kota lain
- New York City, NY15 studi
- Houston, TX13 studi
- Boston, MA13 studi
- Baltimore, MD12 studi
- Chicago, IL11 studi
- Washington, DC10 studi
- San Francisco, CA8 studi
- Durham, NC8 studi
- Atlanta, GA8 studi
- San Diego, CA7 studi
- Los Angeles, CA6 studi
- Pittsburgh, PA6 studi
Studi lain di Cincinnati
- Kanker Paru Non-Sel Kecil35 studi
- Kanker (semua jenis)27 studi
- Kanker Payudara25 studi
- Gagal Jantung24 studi
- Kanker Kolorektal21 studi
- Kanker Metastatik21 studi
- Leukemia Mieloid Akut20 studi
- Kanker Ovarium19 studi
- Obesitas19 studi
- Kanker Paru19 studi
- Kanker Prostat18 studi
- Melanoma17 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.